1832 Asset Management L.P. lowered its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 2.8% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,463,938 shares of the healthcare conglomerate’s stock after selling 42,321 shares during the period. UnitedHealth Group comprises about 1.4% of 1832 Asset Management L.P.’s investment portfolio, making the stock its 20th biggest holding. 1832 Asset Management L.P.’s holdings in UnitedHealth Group were worth $364,683,000 as of its most recent filing with the Securities & Exchange Commission.
Other large investors also recently modified their holdings of the company. Crewe Advisors LLC acquired a new stake in shares of UnitedHealth Group in the 4th quarter valued at $25,000. Pearl River Capital LLC acquired a new stake in shares of UnitedHealth Group in the 4th quarter valued at $35,000. Ipswich Investment Management Co. Inc. acquired a new stake in shares of UnitedHealth Group in the 4th quarter valued at $40,000. OLD Second National Bank of Aurora lifted its stake in shares of UnitedHealth Group by 70.0% in the 4th quarter. OLD Second National Bank of Aurora now owns 170 shares of the healthcare conglomerate’s stock valued at $42,000 after purchasing an additional 70 shares during the last quarter. Finally, Laurel Wealth Advisors LLC acquired a new stake in shares of UnitedHealth Group in the 4th quarter valued at $42,000. 86.68% of the stock is owned by institutional investors.
In other news, Director Richard T. Burke sold 5,000 shares of the business’s stock in a transaction dated Tuesday, March 12th. The shares were sold at an average price of $245.01, for a total transaction of $1,225,050.00. Following the transaction, the director now owns 182,372 shares in the company, valued at approximately $44,682,963.72. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Gail R. Wilensky sold 2,930 shares of the business’s stock in a transaction dated Thursday, March 14th. The stock was sold at an average price of $253.39, for a total transaction of $742,432.70. Following the transaction, the director now owns 64,726 shares in the company, valued at approximately $16,400,921.14. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 17,930 shares of company stock worth $4,587,133. Insiders own 0.87% of the company’s stock.
UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $3.73 earnings per share for the quarter, topping the Zacks’ consensus estimate of $3.60 by $0.13. The firm had revenue of $60.30 billion during the quarter, compared to analyst estimates of $59.72 billion. UnitedHealth Group had a net margin of 5.45% and a return on equity of 25.07%. The business’s revenue was up 9.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $3.04 EPS. Equities analysts forecast that UnitedHealth Group Inc will post 14.7 earnings per share for the current fiscal year.
Several research firms recently issued reports on UNH. Stephens began coverage on shares of UnitedHealth Group in a research note on Monday, January 14th. They issued an “overweight” rating and a $287.00 price objective for the company. ValuEngine lowered shares of UnitedHealth Group from a “hold” rating to a “sell” rating in a research note on Thursday. Zacks Investment Research raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $279.00 price objective for the company in a research note on Saturday, January 5th. Barclays reduced their price objective on shares of UnitedHealth Group from $290.00 to $270.00 and set an “overweight” rating for the company in a research note on Wednesday, April 17th. Finally, SunTrust Banks cut their target price on shares of UnitedHealth Group to $300.00 and set a “buy” rating for the company in a research report on Wednesday, April 17th. They noted that the move was a valuation call. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, eighteen have assigned a buy rating and one has given a strong buy rating to the company. UnitedHealth Group presently has an average rating of “Buy” and a consensus target price of $291.56.
ILLEGAL ACTIVITY NOTICE: This report was originally published by Baseball Daily News and is the sole property of of Baseball Daily News. If you are reading this report on another domain, it was illegally stolen and republished in violation of international copyright & trademark laws. The legal version of this report can be viewed at https://www.baseballdailydigest.com/news/2019/04/22/1832-asset-management-l-p-decreases-holdings-in-unitedhealth-group-inc-unh.html.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Further Reading: Yield Curve
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.